Current Status of Clinical Trials on Tau Immunotherapies.

Drugs
Changyi Ji, Einar M Sigurdsson

Abstract

Tau immunotherapies have advanced from proof-of-concept studies to over a dozen clinical trials for Alzheimer's disease (AD) and other tauopathies. Mechanistic studies in animal and culture models have provided valuable insight into how these therapies may work but multiple pathways are likely involved. Different groups have emphasized the importance of intracellular vs extracellular antibody-mediated clearance of the tau protein and there is no consensus on which pool of tau should ideally be targeted. Likewise, various normal and disease-selective epitopes are being targeted, and the antibody isotypes either favor phagocytosis of the tau-antibody complex or are neutral in that aspect. Most of the clinical trials are in early stages, thus their efficacy is not yet known, but all have been without any major adverse effects and some have reported target engagement. A few have been discontinued. One in phase I, presumably because of a poor pharmacokinetic profile, and three in phase II for a lack of efficacy although this trial stage is not well powered for efficacy measures. In these phase II studies, trials with two antibodies in patients with progressive supranuclear palsy or other primary tauopathies were halted but are conti...Continue Reading

References

Jul 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·I Grundke-IqbalL I Binder
Nov 25, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Tsugunobu Andoh, Yasushi Kuraishi
Nov 2, 2004·Journal of Neural Transmission·C-X GongK Iqbal
Apr 27, 2005·Annals of Neurology·Murray GrossmanVirginia M-Y Lee
Aug 24, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Ayodeji A AsuniEinar M Sigurdsson
Jul 12, 2008·Molecular Neurodegeneration·Fei Liu, Cheng-Xin Gong
Oct 28, 2008·Journal of Alzheimer's Disease : JAD·Einar M Sigurdsson
Jun 9, 2009·Nature Cell Biology·Florence ClavagueraMarkus Tolnay
Feb 6, 2010·The Journal of Allergy and Clinical Immunology·Hanneke van der KleijJohn Bienenstock
Sep 10, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Hans ZempelEva-Maria Mandelkow
Dec 15, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Allal BoutajangoutEinar M Sigurdsson
Jan 11, 2011·Neurochemistry International·Ludovic MartinFaraj Terro
Feb 24, 2011·The Journal of Biological Chemistry·David T HickmanAndreas Muhs
Jun 18, 2011·Current Alzheimer Research·A BoutajangoutP K Krishnamurthy
Sep 16, 2011·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Kaoru YamadaDavid M Holtzman
Oct 26, 2011·Frontiers in Psychiatry·Pavan K KrishnamurthyEinar M Sigurdsson
Mar 31, 2012·The Journal of Biological Chemistry·Najla KfouryMarc I Diamond
Jun 7, 2012·Neurobiology of Disease·Xiyun ChaiMartin Citron
Sep 11, 2012·Brain : a Journal of Neurology·Paula Fernandez-VizarraCarmen Gomez-Guerrero
Apr 25, 2013·International Review of Psychiatry·Chadwick M Hales, William T Hu
May 21, 2013·Lancet Neurology·Maria Grazia Spillantini, Michel Goedert
Jul 25, 2013·Frontiers in Neurology·Julia E Gerson, Rakez Kayed
Oct 12, 2013·PloS One·Jere E MeredithCharles F Albright
Feb 19, 2014·The Journal of Experimental Medicine·Kaoru YamadaDavid M Holtzman
Mar 22, 2014·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Diana L Castillo-CarranzaRakez Kayed
Jun 3, 2014·Neuroscience Letters·Ken C WallsFrank M LaFerla
Jun 6, 2014·Journal of Neurology, Neurosurgery, and Psychiatry·Dana WagshalAdam L Boxer
Jun 15, 2014·Acta Neuropathologica Communications·Julia E GersonRakez Kayed
Jul 22, 2014·Journal of Neurochemistry·Arne IttnerLars M Ittner
Dec 3, 2014·Neurobiology of Aging·Jessica BrightIrene Griswold-Prenner
Dec 17, 2014·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Senthilkumar KrishnaswamyEinar M Sigurdsson

❮ Previous
Next ❯

Citations

Aug 14, 2021·Nature Medicine·Edwin Jabbari, Karen E Duff
Nov 5, 2021·Der Nervenarzt·Lutz Frölich, Lucrezia Hausner

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.